“abgenix” Archives

in
Entry Author Date Location
HardTech Labs Names Veteran Biotech Scientist as Accelerator’s CTO 03/03/16 San Diego
Adicet Joins the Immunotherapy Fray With $51M and Mystery Cells 01/27/16 San Francisco
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
With Invesco’s Support, PureTech Boosts Power to Back Startups 10/20/14 Boston
Assigning Credit and Blame to Biopharma R&D Chiefs 05/29/13 Seattle
MIT-Born Enumeral Advances Human-Based Method for Hunting Drugs 12/20/11 New York
KEW, Led by Millennium Co-Founder, Seeks to Bring Big-Time Cancer Care to Community Clinics 04/27/11 Boston
Plexxikon Cancer Drug Extends Lives, Med Devices Lose Swagger, Amgen Sells Fremont Facility, & More Bay Area Life Sciences News 01/21/11 San Francisco
Boehringer Buys Amgen Fremont 01/19/11 San Francisco
Ablexis Cuts Deal With Pfizer, Four Other Pharmas, For Antibody Drug Discovery Tool 10/26/10 San Francisco
Cytomx, Backed by Third Rock & Roche, Raises $30M for New Class of Antibodies 09/23/10 San Francisco
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader 08/17/10 San Francisco
Third Rock Ventures, Firm With Hunger for Audacious Biotech Ideas, Sets up SF Shop 08/12/10 San Francisco
Metamark Genetics Raises $22M to Find Genetic Signs of Tumor Progression 07/13/10 Boston
Ablexis Maps Out New Antibody Drug Strategy with $12M From Third Rock, Pfizer 06/23/10 San Francisco
Biotech Drug Discovery in Seattle: A Look Back 06/11/10 Seattle
The Future of Biotech Is in Rabbits, Says Entrepreneur Johnny Stine 07/30/08 Seattle
Big Drugmakers Pool Resources, Creating New Company Built to Improve R&D 07/10/08 Boston
Three Luminaries, Two Third Revolutions, and One Nice Suit: An Xconomy Forum on the Future of Life Sciences in New England 05/02/08 Boston
Page 1 of 1